Allotera Therapeutics
PrivateLast Round
Series C
Extension
Jul 8, 2026
Total Funding Raised
$186M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Allotera Therapeutics is a clinical-stage biotechnology company developing allogeneic, off-the-shelf CAR-T cell therapies for cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Allotera Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Allotera Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Jul 8, 2026 | ||||
| Series C | Aug 27, 2025 |
Allotera Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LYZZ Capital | Series C, Series A |
| Intermediate Capital Group | Series C |
| Fidelity Management & Research Company | Series C |
| BioGenerator Ventures | Series A, Series C Extension |
| Tybourne Capital Management | Series C |
| RiverVest Venture Partners | Series C, Series A |
| Abingworth | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 8, 2026
$35M round with BioGenerator Ventures and LightChain Capital.
- Aug 27, 2025
$115M round led by Fidelity Management & Research Company.
Allotera Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Allotera Therapeutics's valuation, stock price, and market status.